CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CALC CALCIMEDICA

盘前交易 07-01 06:17:48 EDT

3.96

+0.81

+25.71%

最高3.96	最低3.17	成交量24.67万
今开3.20	昨收3.15	日振幅25.08%
总市值4,257万	流通市值1,804万	总股本1,075万
成交额86.85万	换手率5.41%	流通股本455.63万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CALC","market":"US","secType":"STK","nameCN":"CALCIMEDICA","latestPrice":3.96,"timestamp":1719604800000,"preClose":3.15,"halted":0,"volume":246694,"delay":0,"floatShares":4556269,"shares":10749065,"eps":-2.22827,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.81,"latestTime":"07-01 06:17:48 EDT","open":3.2,"high":3.96,"low":3.17,"amount":868539.6855898,"amplitude":0.250794,"askPrice":3.95,"askSize":83,"bidPrice":3.35,"bidSize":150,"shortable":3,"etf":0,"ttmEps":-2.22827,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1719840600000},"adr":0,"listingDate":1601006400000,"adjPreClose":3.96,"postHourTrading":{"tag":"盘后","latestPrice":3.92,"preClose":3.96,"latestTime":"18:53 EDT","volume":2691,"amount":10475.9534,"timestamp":1719615181443},"volumeRatio":1.2460881384125766},"requestUrl":"/m/hq/s/CALC","defaultTab":"news","newsList":[{"id":"2446582501","title":"美国研究综述-Alphabet、Equity Residential、Infinera","url":"https://stock-news.laohu8.com/highlight/detail?id=2446582501","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446582501?lang=zh_cn&edition=full","pubTime":"2024-06-28 20:16","pubTimestamp":1719577011,"startTime":"0","endTime":"0","summary":"    路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Alphabet、Equity Residential 和 Infinera。要闻 * Alphabet Inc   ：罗森布拉特证券公司将其评级从 \"买入 \"下调至 \"中性\"。* Cincinnati Financial Corp   ：花旗集团将其评级从 \"买入 \"上调至 \"买入 * Equity Residential   ：Piper Sandler将其评级从中性上调至增持 * 英飞朗  ：Stifel将其评级从 \"买入 \"下调至 \"持有 以下是路透周五报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BL","BB","DAY","AMP","ARRY","CMG","T","LU0106831901.USD","GOOGL","BP","CHK","AVTR","CRBG","LU1280957306.USD","CRK","DE","AOSL","AFG","BHF","LU0708995401.HKD","APOG","ELAN","LU0109391861.USD","CTLT","LU0128525929.USD","ACCD","DLTR","TXG","IE00BJTD4N35.SGD","LU0061475181.USD","BKR","AR","EQH","CHWY","CRL","AGCO","DAL","CINF","CHPT","LU0494093205.USD","LU2264538146.SGD","DCTH","ALSN","BWIN","CERT","DLR","AFL","CALC"],"gpt_icon":0},{"id":"2446524941","title":"美国研究综述-Equity Residential、高盛、Marsh & Mclennan","url":"https://stock-news.laohu8.com/highlight/detail?id=2446524941","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446524941?lang=zh_cn&edition=full","pubTime":"2024-06-28 15:42","pubTimestamp":1719560556,"startTime":"0","endTime":"0","summary":"    路透6月28日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括 Equity Residential、高盛和 Marsh & Mclennan。要点 * Equity Residential   ：Piper Sandler 将其评级从 \"中性 \"上调至 \"增持\"。* 高盛   ：加拿大皇家银行将目标价从 405 美元上调至 435 美元  * Marsh & Mclennan   ：加拿大皇家银行将目标价从210美元上调至228美元  * Pagerduty Inc   ：丰业银行给予其行业表现评级 * Williams Companies Inc   ：摩根大通将目标价从42美元上调至47美元  以下是路透周五报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GIS","BK4559","EQR","LU0640476718.USD","BK4092","HP","LU0689472784.USD","LU0820561909.HKD","PD","PUMP","WBA","DAL","PTEN","LU0170899867.USD","SM","LU1430594728.SGD","MKC","BK4550","LU1917777945.USD","LBRT","NINE","LU0310800965.SGD","LU1303367103.USD","BP","BKR","NKE","ACCD","LU1668664300.SGD","LU1983260115.SGD","LU1064131342.USD","LU2023250504.SGD","MMC","WMB","BK4501","RXRX","LU1169590202.USD","VKTX","CALC","LU1162221912.USD","GS","GE","BK4558","HAL","BK4552","BK4146","IE00B19Z3581.USD","LU0820562030.AUD","BK4139","APOG","LU0149725797.USD"],"gpt_icon":0},{"id":"2435926695","title":"HC Wainwright & Co.：重申CalciMedica(CALC.US)评级，由买入调整至买入评级, 目标价20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2435926695","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435926695?lang=zh_cn&edition=full","pubTime":"2024-05-14 19:31","pubTimestamp":1715686303,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申CalciMedica(CALC.US)评级，由买入调整至买入评级, 目标价20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514193145876892d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240514193145876892d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC"],"gpt_icon":0},{"id":"2435835885","title":"CalciMedica Inc 报告截至一月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2435835885","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435835885?lang=zh_cn&edition=full","pubTime":"2024-05-14 05:25","pubTimestamp":1715635553,"startTime":"0","endTime":"0","summary":"   * CalciMedica Inc   公布的截至一月份的季度调整后每股收益为1美分，高于去年同期的每股收益23.43美元。四位分析师对该季度的平均预期是每股亏损 67 美分。华尔街预期为每股亏损 1.22 美元至-45 美分。* CalciMedica Inc 报告的本季度每股收益为 1 美分。* 公司报告的季度净收入为 13 万美元。* CalciMedica Inc 的股价本季度上涨了 34.6%，今年迄今为止上涨了 95.8%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 CalciMedica Inc 的 12 个月目标价中位数为 17.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","CALC"],"gpt_icon":0},{"id":"2434142869","title":"CalciMedica Inc   预计每股亏损67美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2434142869","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2434142869?lang=zh_cn&edition=full","pubTime":"2024-05-11 00:31","pubTimestamp":1715358674,"startTime":"0","endTime":"0","summary":"   * CalciMedica Inc    预计在5月13日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG分析师对CalciMedica公司的平均预期是每股亏损67美分。* 在过去三个月中，分析师的平均盈利预期上升了约 9.4%。* 华尔街对 CalciMedica Inc 的 12 个月目标价中位数为 17.00 美元，高于其上次收盘价 5.65 美元。5月10日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC"],"gpt_icon":0},{"id":"2423482854","title":"Calcimedica, Inc.2023财年实现净利润-34.36百万美元，同比增加3.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2423482854","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2423482854?lang=zh_cn&edition=full","pubTime":"2024-03-29 14:14","pubTimestamp":1711692884,"startTime":"0","endTime":"0","summary":"12月31日，Calcimedica, Inc.公布财报，公告显示公司2023财年净利润为-34.36百万美元，同比增加3.51%；其中营业收入为0.00美元，每股基本收益为-7.66美元。从资产负债表来看，Calcimedica, Inc.总负债4.03百万美元，其中短期债务--，资产负债比为3.03，流动比率为2.89。机构评级：截至2023年12月31日，当前有4家机构对Calcimedica, Inc.目标价做出预测，其中目标均价为16.38美元，其中最低目标价为9.50美元，最高目标价为22.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032914144987c3dca7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032914144987c3dca7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CALC"],"gpt_icon":0},{"id":"2422988871","title":"CalciMedica Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2422988871","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422988871?lang=zh_cn&edition=full","pubTime":"2024-03-28 20:22","pubTimestamp":1711628543,"startTime":"0","endTime":"0","summary":"   * CalciMedica Inc   报告了截至12月底的季度调整后每股亏损23美分。四位分析师对该季度的平均预期是每股亏损87美分。华尔街预期为每股亏损 1.14 美元至-60 美分。* CalciMedica Inc 公布的本季度每股收益为亏损 23 美分。* CalciMedica Inc 的股价本季度上涨了 46.5%。3月28日 - 预测变化   * 在过去三个月中，分析师的平均盈利预测上升了约 14%。华尔街对 CalciMedica Inc 的 12 个月目标价中位数为 17.00 美元。本摘要由 LSEG 3 月 28 日中午 12:22  的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CALC","BK4007"],"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BHVN","FUN","AGIO","CF","ALB","IE00BFSS8Q28.SGD","CVNA","LU0820562030.AUD","BWA","BXMT","NVDA","BK4090","APD","IE00BJJMRX11.SGD","AIG","ARCH","AORT","BHF","AMAT","LU0109391861.USD","LU0316494557.USD","LU2065171311.SGD","CMBM","AWK","LU1815336760.USD","CACI","TXG","LU0208291251.USD","ANGO","BJRI","LU2249611893.SGD","CWST","AR","CBT","BK4548","CDRE","CBRE","ANGI","ATRC","APLE","BLZE","BIO","AEL","BPMC","ANAB","BE","ALNY","HOUS","ANIP","CALC"],"gpt_icon":0},{"id":"2411251632","title":"美国研究综述-英伟达、Albemarle、Dropbox","url":"https://stock-news.laohu8.com/highlight/detail?id=2411251632","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411251632?lang=zh_cn&edition=full","pubTime":"2024-02-16 17:25","pubTimestamp":1708075529,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CUBE","FR","CEVA","BIO","BK4224","CBT","CBRE","AGIO","EQIX","AIG","ED","CRBG","ALB","ARCH","FBRT","BK4543","CALC","TXG","ATRC","GPMT","APD","EPAM","LU1244550577.SGD","EGP","IE00B7KXQ091.USD","BK4156","LU0316494557.USD","DASH","GPC","ALNY","CRL","SGXZ23171101.USD","BK4545","COIN","NVDA","HASI","DBX","EXR","AMAT","HBI","LU0053666078.USD","BE","AR","AEL","DE","GTLB","DKNG","EAF","CROX","BXMT"],"gpt_icon":0},{"id":"2411635884","title":"美国研究综述-阿尔伯马尔、Dropbox、泰勒科技公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2411635884","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411635884?lang=zh_cn&edition=full","pubTime":"2024-02-16 15:19","pubTimestamp":1708067998,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Tyler Technologies。要闻  * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Deere & Co   ：大和资本市场将目标价从425美元下调至400美元  * Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元              * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CEVA","AMAT","GPC","LU1496350171.SGD","ATRC","HASI","CRBG","ALNY","PEGA","HBI","LU0011850046.USD","PDFS","BK4146","BK4550","NVDA","HTGC","AGIO","IRTC","LU1668664300.SGD","AIG","NKE","KNF","LU1244550221.USD","NSIT","CROX","IRWD","DE","LU0385154629.USD","CALC","CBT","DBX","MGY","PANW","BXMT","LU0957791311.USD","ALB","BE","FBRT","LU1642822529.SGD","MVBF","NOG","AEL","EQIX","CBRE","EPAM","TYL","BK4110","AR","NRIX","GPMT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.calcimedica.com","stockEarnings":[{"period":"1week","weight":-0.2598},{"period":"1month","weight":-0.2734},{"period":"3month","weight":-0.0481},{"period":"6month","weight":0.3515},{"period":"1year","weight":-0.1835},{"period":"ytd","weight":0.3515}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0344},{"period":"3month","weight":0.0404},{"period":"6month","weight":0.145},{"period":"1year","weight":0.2422},{"period":"ytd","weight":0.145}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CalciMedica, Inc.于2015年2月根据特拉华州法律成立。该公司是一家临床阶段的生物制药公司，专注于开发治疗威胁生命的炎症性疾病的疗法，这些疾病的需求尚未得到满足。该公司的专有技术旨在抑制钙释放激活钙（CRAC）通道，该通道旨在调节免疫反应并防止组织细胞损伤，有可能在威胁生命的炎症性疾病中提供治疗益处，目前还没有获得批准的治疗方法。该公司的主要候选产品Auxora是一种专有的、静脉配制的CRAC通道抑制剂，已在四项已完成的疗效临床试验中显示出积极和一致的临床结果。Auxora正在开发用于急性胰腺炎和门冬酰胺酶相关胰腺炎。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.425181},{"month":2,"riseRate":0,"avgChangeRate":-0.241659},{"month":3,"riseRate":0,"avgChangeRate":-0.299918},{"month":4,"riseRate":0.25,"avgChangeRate":-0.031156},{"month":5,"riseRate":0.25,"avgChangeRate":-0.049488},{"month":6,"riseRate":0.75,"avgChangeRate":0.090452},{"month":7,"riseRate":0,"avgChangeRate":-0.210501},{"month":8,"riseRate":0.666667,"avgChangeRate":0.00866},{"month":9,"riseRate":0,"avgChangeRate":-0.152684},{"month":10,"riseRate":0.666667,"avgChangeRate":0.015449},{"month":11,"riseRate":0.5,"avgChangeRate":0.229824},{"month":12,"riseRate":0.25,"avgChangeRate":-0.162555}],"exchange":"NASDAQ","name":"CALCIMEDICA","nameEN":"CALCIMEDICA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CALCIMEDICA,CALC,CALCIMEDICA股票,CALCIMEDICA股票老虎,CALCIMEDICA股票老虎国际,CALCIMEDICA行情,CALCIMEDICA股票行情,CALCIMEDICA股价,CALCIMEDICA股市,CALCIMEDICA股票价格,CALCIMEDICA股票交易,CALCIMEDICA股票购买,CALCIMEDICA股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CALCIMEDICA(CALC)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CALCIMEDICA(CALC)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况